The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 3,017
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Suzuki, Y., Nakabayashi, Y., & Takahashi, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161506698 · Cited by 654
Livin, a Novel Inhibitor of Apoptosis Protein Family Member
Kasof, G. M., & Gomes, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003670200 · Cited by 454
Woo, J.-H., Kim, Y.-H., Choi, Y.-J., Kim, D.-G., Lee, K.-S., Bae, J. H., Min, D. S., Chang, J.-S., Jeong, Y.-J., Lee, Y. H., et al. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg082 · Cited by 442
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290355 · Cited by 396
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
Bush, J. A., Cheung, K.-J. J., & Li, G. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5381 · Cited by 385
Goel, A., Boland, C. R., & Chauhan, D. P. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00655-3 · Cited by 381
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.11.4079 · Cited by 367
Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y., & Orlowski, R. Z. (2002) · PubMed · Cited by 336
Survivin promotes cell proliferation in human hepatocellular carcinoma
Ito, T., Shiraki, K., Sugimoto, K., Yamanaka, T., Fujikawa, K., Ito, M., Takase, K., Moriyama, M., Kawano, H., Hayashida, M., et al. (2000) · Hepatology · doi:10.1053/he.2000.6496 · Cited by 329
Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro
MacFarlane, M., Merrison, W., Bratton, S. B., & Cohen, G. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200317200 · Cited by 301
Shishodia, S., Potdar, P., Gairola, C. G., & Aggarwal, B. B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg078 · Cited by 292
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Duyao, M. P., Buckler, A. J., & Sonenshein, G. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4727 · Cited by 278
Expression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins1
Li, J., Feng, Q., Kim, J.-M., Schneiderman, D., Liston, P., Li, M., Vanderhyden, B., Faught, W., Fung, M. F. K., Senterman, M., et al. (2001) · Endocrinology · doi:10.1210/endo.142.1.7897 · Cited by 185
Chuang, S.-E., Yeh, P.-Y., Lu, Y.-S., Lai, G.-M., Liao, C.-M., Gao, M., & Cheng, A.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00931-0 · Cited by 159
Liu, P., Kimmoun, E., Legrand, A., Sauvanet, A., Degott, C., Lardeux, B. R., & Bernuau, D. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00064-8 · Cited by 149
Chan, M. M.-Y., Fong, D., Soprano, K. J., Holmes, W. F., & Heverling, H. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10186 · Cited by 140
Hour, T., Chen, J., Huang, C., Guan, J., Lu, S., & Pu, Y. (2002) · The Prostate · doi:10.1002/pros.10089 · Cited by 130
Zhou, M., Gu, L., Li, F., Zhu, Y., Woods, W. G., & Findley, H. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037192 · Cited by 130
Ashikawa, K., Shishodia, S., Fokt, I., Priebe, W., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.039 · Cited by 97
Notarbartolo, M., Cervello, M., Dusonchet, L., Cusimano, A., & D’Alessandro, N. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00834-5 · Cited by 92
Self-citationc-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella, A., Gramlich, T. L., Fritsch, C., & Gansler, T. S. (1996) · PubMed · Cited by 85
Role of Rel/NF‐κB transcription factors in apoptosis of human hepatocellular carcinoma cells
Chiao, P. J., Na, R., Niu, J., Sclabas, G. M., Dong, Q., & Curley, S. A. (2002) · Cancer · doi:10.1002/cncr.10829 · Cited by 75
Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma
Shiraki, K., Sugimoto, K., Yamanaka, Y., Yamaguchi, Y., Saitou, Y., Ito, K., Yamamoto, N., Yamanaka, T., Fujikawa, K., Murata, K., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.5.705 · Cited by 63
Matsumiya, T. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00102-0 · Cited by 28
Hu, Y., Bally, M. B., Dragowska, W. H., & Mayer, L. D. (2003) · PubMed · Cited by 21
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Ravindran, J., Prasad, S., & Aggarwal, B. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9128-x · Cited by 768
Metadata
- Authors
- Notarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M., & D'Alessandro, N.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 224
- Issue
- 1
- Pages
- 53-65
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2001723288
- Cited by
- 317
- References
- 34
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.